Skip to main content

Advertisement

Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels

Fig. 3

The sdLDL-C levels stratified by the “LDL window” and the “alternative LDL window” of healthy subjects, patients with diabetes, and patients with CAD. Top panel: small dense (sd) LDL-C levels stratified by triglycerides (TG) and apolipoprotein B (apoB) in healthy subjects (n = 1665), patients with diabetes (n = 201), and patients with CAD (n = 528). The “LDL window” comprises the groups as follows: normal (apoB <110 mg/dL and TG <150 mg/dL), hyper-TG (apoB <110 mg/dL and TG ≥150 mg/dL), hyper-apoB (apoB ≥110 mg/dL and TG <150 mg/dL), and hyper-TG/-apoB (apoB ≥110 mg/dL and TG ≥150 mg/dL). Bottom panel: sdLDL-C levels stratified by TG and non-HDL-C in healthy subjects (n = 1665), patients with diabetes (n = 201), and patients with CAD (n = 528). The “alternative LDL window” comprises the groups as follows: normal (non-HDL-C <170 mg/dL and TG <150 mg/dL), hyper-TG (non-HDL-C <170 mg/dL and TG ≥150 mg/dL), hyper-non-HDL (non-HDL-C ≥170 mg/dL and TG <150 mg/dL), and hyper-TG/-non-HDL (non-HDL-C ≥170 mg/dL and TG ≥150 mg/dL).

Back to article page